TRIM38 Inhibitors
Chemical inhibitors of TRIM38 can affect its function through various mechanisms, predominantly by interfering with the autophagic and proteasomal degradation pathways that TRIM38 is known to regulate. MG132, as a proteasome inhibitor, can prevent the degradation of proteins that are tagged for destruction by TRIM38's E3 ubiquitin ligase activity. This inhibition results in an accumulation of ubiquitinated proteins, which can lead to a functional block in TRIM38-mediated turnover of these substrates. Chloroquine acts by increasing the pH within lysosomes, effectively dampening the autophagic process wherein TRIM38 is involved. By disrupting the acidic environment necessary for lysosomal enzymes to function, Chloroquine indirectly hinders TRIM38's role in autophagic degradation.
Moreover, autophagy relies on the formation and maturation of autophagosomes, processes that are controlled by signaling pathways involving PI3K. Here, 3-Methyladenine and LY294002 both serve as PI3K inhibitors, suppressing the autophagic pathway and thus impeding TRIM38's function in autophagosome turnover. Bafilomycin A1, another inhibitor that targets the V-ATPase necessary for lysosomal acidification, can also impair the autophagic process regulated by TRIM38. E64d and Leupeptin, which inhibit cysteine and serine proteases respectively, and Pepstatin A, which inhibits aspartyl proteases, all contribute to the disruption of lysosomal proteolysis. This disruption can lead to a functional inhibition of TRIM38 as it prevents the final degradation step of autophagy. Additionally, Spautin-1 targets ubiquitin-specific peptidases USP10 and USP13, leading to the accumulation of ubiquitinated proteins and disturbing the autophagic flux, thereby affecting TRIM38's associated activities. Saracatinib and KU-55933 are inhibitors that target signaling pathways; by inhibiting Src kinase and ATM kinase, respectively, they can interfere with the cellular signaling processes that modulate TRIM38's function. These chemical inhibitors collectively demonstrate the ability to modulate the activity of TRIM38 by targeting different aspects of the cellular degradation pathways in which TRIM38 is a critical component.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can inhibit the degradation of ubiquitinated proteins. Since TRIM38 has E3 ubiquitin ligase activity, MG132 can functionally inhibit TRIM38 by preventing the proteasomal degradation of its substrates, thereby inhibiting the protein turnover process that TRIM38 regulates. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to alkalize lysosomal pH. TRIM38 is implicated in the process of autophagy, which requires acidic lysosomal environments for degradation of autophagic vesicles. By increasing lysosomal pH, Chloroquine can inhibit the lysosomal degradation pathway, which is essential for the autophagic process that TRIM38 is involved in. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is an inhibitor of phosphoinositide 3-kinases (PI3K). TRIM38 has been reported to participate in the regulation of autophagy, a cellular process that depends on PI3K activity. By inhibiting PI3K, 3-Methyladenine can suppress the autophagic pathway and thereby functionally inhibit TRIM38. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 specifically inhibits V-ATPase, which is vital for acidification of lysosomes. TRIM38 is involved in autophagy, which relies on lysosomal degradation. Inhibition of V-ATPase by Bafilomycin A1 can impede lysosomal acidification, thus functionally inhibiting the autophagic process where TRIM38 is active. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is a reversible inhibitor of serine and cysteine proteases, such as those in lysosomes. By inhibiting these proteases, Leupeptin can impede the lysosomal degradation pathway. Considering TRIM38's role in autophagy, which involves lysosomal degradation, Leupeptin's mechanism of action can functionally inhibit TRIM38 by disrupting the autophagy-related degradation that it regulates. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
Spautin-1 is an inhibitor of ubiquitin-specific peptidases USP10 and USP13, which are involved in autophagy. TRIM38 is associated with the regulation of autophagy. By inhibiting these peptidases, Spautin-1 can lead to the accumulation of ubiquitinated proteins and disrupt autophagic flux, thereby functionally inhibiting TRIM38 activity in autophagy. | ||||||
Saracatinib | 379231-04-6 | sc-364607 sc-364607A | 10 mg 200 mg | $115.00 $1056.00 | 7 | |
Saracatinib is a Src kinase inhibitor. Src kinase activity has been implicated in various signaling pathways, including those regulating autophagy. By inhibiting Src kinase, Saracatinib can disrupt signaling required for autophagy, where TRIM38 is known to play a role, thus functionally inhibiting TRIM38. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
KU-55933 is an inhibitor of ATM kinase, which is part of the DNA damage response. TRIM38 is known to be involved in innate immune signaling and may be regulated by DNA damage responses. By inhibiting ATM kinase, KU-55933 can alter signaling pathways that involve TRIM38, providing functional inhibition of TRIM38's role in these pathways. | ||||||